University of North Carolina at Chapel Hill
Chapel Hill, United States
Publications on this disease100
Research view
Switch to patient viewAsthma: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target or a country to narrow the list.
- All targets
- NLRP3 0
- IL-4 0
- MAPK 0
- PI3K 0
- TSLP 2
- STAT3 0
- AKT 0
- IL-13 0
- mTOR 0
- NRF2 0
- TNF 0
- TLR4 0
- GLP-1 0
- IL-17 0
- JAK 1
- PPAR 0
- HIF-1 0
- IL-6 0
- JNK 0
- AMPK 0
- ERK 0
- CD40 0
- COX-2 0
- HMGB1 0
- IL-1 1
- MMP-9 0
- STING 0
- EGFR 0
- SIRT1 0
- TP53 0
- YAP 0
- CTNNB1 0
- GPX4 0
- METTL3 0
- PD-1 0
- PDE4 0
- PTEN 0
- VEGF 0
- CCR5 0
- CFTR 0
- PD-L1 0
- PKM2 0
- ALK 1
- BDNF 0
- CD19 0
- CD38 0
- CXCR4 0
- FGFR 0
- FTO 0
- GIP 0
- HDAC 0
- IGF1R 0
- IL-23 0
- KIT 0
- MYC 0
- PCSK9 0
- SGLT2 0
- STK11 0
- ACE2 0
- APOE 0
1 of 1+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
NIH NIAMS · F32
Understanding the role of innate lymphoid cells within psoriasis relapse
NIH NHLBI · R01
NIH NHLBI · R01
Shortening the Diagnostic Odyssey for Children with Rare Pulmonary Diseases (RPD)
NIH NHLBI · R43
Developing a novel, non-invasive wearable device for COPD diagnosis andMonitoring
NIH OD · N01
NHLBI MAINTENANCE OF CANINE MODELS OF HUMAN BLEEDING DISORDERS
European Commission (Horizon Europe) · HORIZON-ERC
Targeting airway lymphocytes in asthma and biologics treatment (TARGET-AIR-LAB)
European Commission (Horizon Europe) · HORIZON-CSA
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
The disease is named only in the funder's project summary, not in the title.
10 of 927 running projects, newest first. Listed amounts together: US$603.0m + €58.2m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 18
- Organoids 2
- Mendelian Randomization Analysis 81
- Gene Expression Profiling 73
- Sequence Analysis, RNA 7
- Whole Genome Sequencing 1
- Exome Sequencing 2
- Proteomics 26
- Metabolomics 47
- Mass Spectrometry 16
- Flow Cytometry 18
- Immunohistochemistry 12
- Liquid Biopsy 1
- Xenograft Model Antitumor Assays 1
- Positron-Emission Tomography 1
- Magnetic Resonance Imaging 12
- Machine Learning 69
- Deep Learning 10
- Cohort Studies 249
- Genome-Wide Association Study 100
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.